In trading on Thursday, shares of Spire Inc (SR - Get Report) crossed below their 200 day moving average of $64.28, changing hands as low as $64.15 per share. Spire Inc shares are currently trading down about 0.4% on the day. The chart below shows the one year performance of SR shares, versus its 200 day moving average:Looking at the chart above, SR's low point in its 52 week range is $49.66 per share, with $71.21 as the 52 week high point — that compares with a last trade of $64.42. According to the ETF Finder at ETF Channel, SR makes up 2.30% of the PowerShares DWA Utilities Momentum Portfolio ETF ( PUI) which is trading lower by about 0.5% on the day Thursday.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Financial Market Behavior, General Mills Earnings: Market Recon
Markets must choose now between the easy, the tense and the uncertain. What could possibly go wrong?
Del Frisco's to Be Acquired for $650 Million by Private-Equity Firm L Catterton
Del Frisco's is being acquired by private-equity firm L Catterton for $8 a share.
Bristol-Myers Plans Otezla Sale to Win FTC Approval for $74 Billion Celgene Deal
Bristol-Myers Squibb shares slumped lower in pre-market trading Monday after the group said the U.S. Federal Trade Commission was still looking into its proposed $74 billion takeover of cancer specialist Celgene and that it would sell that company's psoriasis to push the deal through.